Genetics & Environmental Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics & Environmental Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomimetics
Codexis-Shell Oil Announcement a Bellwether for Cross-Disciplinary Investments Says CMEA Ventures
November 22nd, 2007
The announcement that Royal Dutch Shell plc has extended its research collaboration with privately-held biotech company Codexis by 5 years, accompanied by an undisclosed equity investment in Codexis, is a strong indication that cross-disciplinary venture investments show increasing promise, says CMEA Ventures founder Tom Baruch. (See "Shell and Codexis Expand Collaboration to Explore New Super Enzymes for Next Generation Biofuels", November 6, 2007). Cross- or multi-disciplinary ventures are those that apply novel ideas or cutting-edge science and technology from one discipline to new products, processes or procedures in another unrelated, or distantly-related field. In...
Source: Genetics & Environmental Business Week (2007-11-22)
|
